While the trade policies of TRIPS and, in particular its strong protection for intellectual property rights in the pharmaceutical sector, continue to drive health costs upwards, potential regulatory doctrines aimed at reducing those costs often remain underutilized or ineffective. This chapter...

The future and value of firms, their industries and the economy may well hinge in the long run on the outcome of sustainability efforts across a multitude of industries on a global basis. The authors have previously reported on the sustainability programs and sustainable value in the Food and...